Natera (NTRA) Cash & Equivalents Growth (3y) (2017 - 2026)
Natera (NTRA) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 70.63% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 35.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.74% |
| Dec 31, 2025 | 32.17% |
| Sep 30, 2025 | 159.65% |
| Jun 30, 2025 | 122.01% |
| Mar 31, 2025 | 83.14% |
| Dec 31, 2024 | 123.57% |
| Sep 30, 2024 | 110.96% |
| Jun 30, 2024 | 1,417.53% |
| Mar 31, 2024 | 132.05% |
| Dec 31, 2023 | 135.99% |
| Sep 30, 2023 | 47.27% |
| Jun 30, 2023 | 70.18% |
| Mar 31, 2023 | 75.88% |
| Dec 31, 2022 | 1,938.78% |
| Sep 30, 2022 | 912.73% |
| Jun 30, 2022 | 1,084.41% |
| Mar 31, 2022 | 635.15% |
| Dec 31, 2021 | 22.17% |
| Sep 30, 2021 | 40.17% |
| Jun 30, 2021 | -73.54% |